Assessment of Exercise Capacity

  • Ioannis Vogiatzis
  • Paolo Palange
  • Pierantonio LavenezianaEmail author


Exercise intolerance is a condition where the patient is unable to undertake physical exercise at the level and/or for the duration that would be expected of someone in his or her age and general physical condition. When this inability is triggered by impaired function of one or more of the physiological systems (i.e. central haemodynamic, respiratory, peripheral muscles), the result is the intensification of the perceptions of dyspnoea, often in conjunction with peripheral muscle discomfort that is often triggered by peripheral muscle fatigue [1].


  1. 1.
    Whipp BJ, Wagner PD, Agusti A. Determinants of the physiological systems responses to muscular exercise in healthy subjects. In:European respiratory monograph. United Kingdom: European Respiratory Society; 2007. p. 30–4.Google Scholar
  2. 2.
    O’Donnell DE, et al. Qualitative aspects of exertional breathlessness in chronic airflow limitation: pathophysiologic mechanisms. Am J Respir Crit Care Med. 1997;155(1):109–15.PubMedCrossRefGoogle Scholar
  3. 3.
    Wagner PD. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol. 1996;58:21–50.PubMedCrossRefGoogle Scholar
  4. 4.
    Mador MJ, Kufel TJ, Pineda L. Quadriceps fatigue after cycle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(2 Pt 1):447–53.CrossRefGoogle Scholar
  5. 5.
    Roca J, et al. Guidelines for interpretation. In: Roca J, Whipp BJ, editors. European respiratory monograph. United Knigdom: European Respiratory Society; 1997. p. 88–114.Google Scholar
  6. 6.
    Killian KJ. Limitation to muscular activity in chronic obstructive pulmonary disease. Eur Respir J. 2004;24(1):6–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Palange P, et al. Recommendation on the use of exercise testing in clinical practice. Eur Respir J. 2007;29:185–209.PubMedCrossRefGoogle Scholar
  8. 8.
    ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.CrossRefGoogle Scholar
  9. 9.
    Singh SJ, et al. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992;47(12):1019–24.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Revill SM, et al. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax. 1999;54(3):213–22.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Troosters T, et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J. 2002;20(3):564–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Onorati P, et al. Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol. 2003;89(3–4):331–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Rice AJ, et al. Pulmonary gas exchange during exercise in highly trained cyclists with arterial hypoxemia. J Appl Physiol. 1999;87(5):1802–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Richardson RS, et al. Determinants of maximal exercise VO2 during single leg knee-extensor exercise in humans. Am J Phys. 1995;268(4 Pt 2):H1453–61.Google Scholar
  15. 15.
    Saltin B, Calbet JA, Wagner PD. Point: in health and in a normoxic environment, VO2 max is limited primarily by cardiac output and locomotor muscle blood flow. J Appl Physiol. 2006;100:744–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Ekblom B, Hermansen L. Cardiac output in athletes. J Appl Physiol. 1968;25(5):619–25.PubMedCrossRefGoogle Scholar
  17. 17.
    Grimby G, Nilsson NJ, Saltin B. Cardiac output during submaximal and maximal exercise in active middle-aged athletes. J Appl Physiol. 1966;21(4):1150–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Mitchell JH, Sproule BJ, Chapman CB. The physiological meaning of the maximal oxygen intake test. J Clin Invest. 1958;37(4):538–47.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Saltin B. Circulatory response to submaximal and maximal exercise after thermal dehydration. J Appl Physiol. 1964;19:1125–32.PubMedCrossRefGoogle Scholar
  20. 20.
    Koskolou MD, et al. Cardiovascular responses to dynamic exercise with acute anemia in humans. Am J Phys. 1997;273(4 Pt 2):H1787–93.Google Scholar
  21. 21.
    Stenberg J, Ekblom B, Messin R. Hemodynamic response to work at simulated altitude, 4,000 m. J Appl Physiol. 1966;21(5):1589–94.PubMedCrossRefGoogle Scholar
  22. 22.
    Roach RC, et al. Arterial O2 content and tension in regulation of cardiac output and leg blood flow during exercise in humans. Am J Phys. 1999;276(2 Pt 2):H438–45.Google Scholar
  23. 23.
    Ekblom B, Wilson G, Astrand PO. Central circulation during exercise after venesection and reinfusion of red blood cells. J Appl Physiol. 1976;40(3):379–83.PubMedCrossRefGoogle Scholar
  24. 24.
    Krip B, et al. Effect of alterations in blood volume on cardiac function during maximal exercise. Med Sci Sports Exerc. 1997;29(11):1469–76.PubMedCrossRefGoogle Scholar
  25. 25.
    Torre-Bueno JR, et al. Diffusion limitation in normal humans during exercise at sea level and simulated altitude. J Appl Physiol. 1985;58(3):989–95.PubMedCrossRefGoogle Scholar
  26. 26.
    Gledhill N, Froese AB, Dempsey JA. Ventilation to perfusion distribution during exercise in health. In: Dempsey JA, Reed CE, editors. Muscular exercise and the lung. Wisconsin: University of Wisconsin; 1977. p. 325–44.Google Scholar
  27. 27.
    Powers SK, et al. Effects of incomplete pulmonary gas exchange on VO2 max. J Appl Physiol. 1989;66(6):2491–5.PubMedCrossRefGoogle Scholar
  28. 28.
    O’Donnell DE, Ofir D, Laveneziana P. Patterns of cardiopulmonary response to exercise in lung diseases. In:European respiratory monograph. United Kingdom: European Respiratory Society; 2007. p. 69–92.Google Scholar
  29. 29.
    Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003a;107(1):139–46.PubMedCrossRefGoogle Scholar
  30. 30.
    Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003b;107(2):346–54.PubMedCrossRefGoogle Scholar
  31. 31.
    Marcinek DJ, et al. Reduced mitochondrial coupling in vivo alters cellular energetics in aged mouse skeletal muscle. J Physiol. 2005;569(Pt 2):467–73.PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    DeLorey DS, Paterson DH, Kowalchuk JM. Effects of ageing on muscle O2 utilization and muscle oxygenation during the transition to moderate-intensity exercise. Appl Physiol Nutr Metab. 2007;32(6):1251–62.PubMedCrossRefGoogle Scholar
  33. 33.
    DeLorey DS, Babb TG. Progressive mechanical ventilatory constraints with aging. Am J Respir Crit Care Med. 1999;160(1):169–77.PubMedCrossRefGoogle Scholar
  34. 34.
    Stathokostas L, et al. Longitudinal changes in aerobic power in older men and women. J Appl Physiol. 2004;97(2):781–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Coggan AR, et al. Histochemical and enzymatic comparison of the gastrocnemius muscle of young and elderly men and women. J Gerontol. 1992;47(3):B71–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Russell JA, et al. Effects of aging on capillary geometry and hemodynamics in rat spinotrapezius muscle. Am J Physiol Heart Circ Physiol. 2003;285(1):H251–8.PubMedCrossRefGoogle Scholar
  37. 37.
    Taylor BJ, Johnson BD. The pulmonary circulation and exercise responses in the elderly. Semin Respir Crit Care Med. 2010;31(5):528–38.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Turner JM, Mead J, Wohl ME. Elasticity of human lungs in relation to age. J Appl Physiol. 1968;25(6):664–71.PubMedCrossRefGoogle Scholar
  39. 39.
    Walsh J, et al. Structural change of the thorax in chronic obstructive pulmonary disease. J Appl Physiol. 1992;72:1270–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Tolep K, et al. Comparison of diaphragm strength between healthy adult elderly and young men. Am J Respir Crit Care Med. 1995;152(2):677–82.PubMedCrossRefGoogle Scholar
  41. 41.
    Johnson BD, Badr MS, Dempsey JA. Impact of the aging pulmonary system on the response to exercise. Clin Chest Med. 1994;15(2):229–46.PubMedGoogle Scholar
  42. 42.
    Johnson BD, et al. Flow limitation and regulation of functional residual capacity during exercise in a physically active aging population. Am Rev Respir Dis. 1991;143(5 Pt 1):960–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Johnson BD, et al. Mechanical constraints on exercise hyperpnea in a fit aging population. Am Rev Respir Dis. 1991;143(5 Pt 1):968–77.PubMedCrossRefGoogle Scholar
  44. 44.
    Harms CA, et al. Respiratory muscle work compromises leg blood flow during maximal exercise. J Appl Physiol. 1997;82(5):1573–83.PubMedCrossRefGoogle Scholar
  45. 45.
    Aliverti A, et al. Human respiratory muscle actions and control during exercise. J Appl Physiol. 1997;83(4):1256–69.PubMedCrossRefGoogle Scholar
  46. 46.
    Vogiatzis I, et al. Respiratory kinematics by optoelectronic plethysmography during exercise in men and women. Eur J Appl Physiol. 2005;93(5–6):581–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Vogiatzis I, et al. Chest wall volume regulation during exercise in COPD patients with GOLD stages II to IV. Eur Respir J. 2008;32(1):42–52.PubMedCrossRefGoogle Scholar
  48. 48.
    Gallagher C. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. Clin Chest Med. 1994;15(2):305–26.PubMedGoogle Scholar
  49. 49.
    American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.CrossRefGoogle Scholar
  50. 50.
    Harms CA. Does gender affect pulmonary function and exercise capacity? Respir Physiol Neurobiol. 2006;151(2–3):124–31.PubMedCrossRefGoogle Scholar
  51. 51.
    Wasserman K, et al. Exercise testing and interpretation: an overview. In: Weinberg WR, editor. Principles of exercise testing and interpretation. Baltimore, PA: Lippincott Williams & Wilkins; 2005. p. 1–9.Google Scholar
  52. 52.
    Dillard TA, Piantadosi S, Rajagopal KR. Prediction of ventilation at maximal exercise in chronic airflow obstruction. Am Rev Respir Dis. 1985;132:230–5.PubMedGoogle Scholar
  53. 53.
    Laveneziana P, Parker CM, O’Donnell DE. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease. Appl Physiol Nutr Metab. 2007;32(6):1225–38.PubMedCrossRefGoogle Scholar
  54. 54.
    MacIntyre NR. Mechanisms of functional loss in patients with chronic lung disease. Respir Care. 2008;53(9):1177–84.PubMedGoogle Scholar
  55. 55.
    Levison H, Cherniack RM. Ventilatory cost of exercise in chronic obstructive pulmonary disease. J Appl Physiol. 1968;25(1):21–7.PubMedCrossRefGoogle Scholar
  56. 56.
    MacIntyre NR, Leatherman NE. Mechanical loads on the ventilatory muscles. A theoretical analysis. Am Rev Respir Dis. 1989;139(4):968–73.PubMedCrossRefGoogle Scholar
  57. 57.
    Casaburi R, et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991;143(1):9–18.PubMedCrossRefGoogle Scholar
  58. 58.
    O’Donnell DE. Exercise limitation and clinical exercise testing in chronic obstructive pulmonary disease. In: Weisman I, Zeballos R, editors. Progress in respiratory research. Basel: Karger; 2002. p. 138–58.Google Scholar
  59. 59.
    West JB. State of the art: ventilation-perfusion relationships. Am Rev Respir Dis. 1977;116(5):919–43.PubMedGoogle Scholar
  60. 60.
    Agusti A, Cotes J, Wagner P. Responses to exercise in lung diseases. In:European respiratory monograph. UK: ERS Journals; 1997. p. 32–50.Google Scholar
  61. 61.
    Hyatt RE. Expiratory flow limitation. J Appl Physiol. 1983;55(1 Pt 1):1–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Martinez FJ, et al. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med. 1997;155(6):1984–90.PubMedCrossRefGoogle Scholar
  63. 63.
    O’Donnell DE, Revill S, Webb K. Dynamic hyperinflation and exercise intolerance in COPD. Am J Respir Crit Care Med. 2001;164:770–7.PubMedCrossRefGoogle Scholar
  64. 64.
    Ferrazza A, et al. Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases. Respiration. 2009;77:3–17.PubMedCrossRefGoogle Scholar
  65. 65.
    Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(1):20–2.PubMedCrossRefGoogle Scholar
  66. 66.
    Agusti AG, et al. Hypoxic pulmonary vasoconstriction and gas exchange during exercise in chronic obstructive pulmonary disease. Chest. 1990;97(2):268–75.PubMedCrossRefGoogle Scholar
  67. 67.
    Agusti AG, et al. Mechanisms of gas-exchange impairment in idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1991;143(2):219–25.PubMedCrossRefGoogle Scholar
  68. 68.
    D’Alonzo GE, et al. Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension. Chest. 1987;92(1):57–62.PubMedCrossRefGoogle Scholar
  69. 69.
    Dantzker DR, D’Alonzo GE. The effect of exercise on pulmonary gas exchange in patients with severe chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986;134(6):1135–9.PubMedGoogle Scholar
  70. 70.
    Dantzker DR, et al. Pulmonary gas exchange during exercise in patients with chronic obliterative pulmonary hypertension. Am Rev Respir Dis. 1984;130(3):412–6.PubMedGoogle Scholar
  71. 71.
    Janicki JS. Influence of the pericardium and ventricular interdependence on left ventricular diastolic and systolic function in patients with heart failure. Circulation. 1990;81(2 Suppl):III15–20.PubMedGoogle Scholar
  72. 72.
    Dempsey JA, Harms CA, Ainsworth DM. Respiratory muscle perfusion and energetics during exercise. Med Sci Sports Exerc. 1996;28(9):1123–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med Sci Sports Exerc. 1996;153(3):976–80.CrossRefGoogle Scholar
  74. 74.
    Hamilton AL, et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2021–31.PubMedCrossRefGoogle Scholar
  75. 75.
    Bernard S, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(2):629–34.PubMedCrossRefGoogle Scholar
  76. 76.
    Serres I, et al. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest. 1998;113(4):900–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Booth F, Gollnick P. Effects of disease on the structure and function of skeletal muscle. Med Sci Sports Exerc. 1983;15(5):415–20.PubMedCrossRefGoogle Scholar
  78. 78.
    Coyle EF, et al. Effects of detraining on responses to submaximal exercise. J Appl Physiol. 1985; 59(3):853–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Mainguy V, et al. Peripheral muscle dysfunction in idiopathic pulmonary arterial hypertension. Thorax. 2010;65(2):113–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Vogiatzis I, Zakynthinos S. Factors limiting exercise tolerance in chronic lung diseases. Compr Physiol. 2012;2(3):1779–817.PubMedGoogle Scholar
  81. 81.
    Johnson B. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.CrossRefGoogle Scholar
  82. 82.
    Puente-Maestu L, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429–60.PubMedCrossRefGoogle Scholar
  83. 83.
    Laviolette L, Laveneziana P. Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014;43(6):1750–62.PubMedCrossRefGoogle Scholar
  84. 84.
    Banzett RB, O’Donnell CR. Should we measure dyspnoea in everyone? Eur Respir J. 2014;43(6):1547–50.PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Gronseth R, et al. Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J. 2014;43(6):1610–20.PubMedCrossRefGoogle Scholar
  86. 86.
    Nishimura K, et al. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434–40.PubMedCrossRefGoogle Scholar
  87. 87.
    Abidov A, et al. Prognostic significance of dyspnea in patients referred for cardiac stress testing. N Engl J Med. 2005;353(18):1889–98.PubMedCrossRefGoogle Scholar
  88. 88.
    Ho SF, et al. Dyspnoea and quality of life in older people at home. Age Ageing. 2001;30(2):155–9.PubMedCrossRefGoogle Scholar
  89. 89.
    Hayton C, et al. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med. 2013;107(3):401–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Parshall MB, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–52.PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Laveneziana P, et al. Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med. 2011;184(12):1367–73.PubMedCrossRefGoogle Scholar
  92. 92.
    Laveneziana P, et al. Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD? Respir Physiol Neurobiol. 2014;199:24–33.PubMedCrossRefGoogle Scholar
  93. 93.
    O’Donnell DE, Hamilton AL, Webb KA. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. J Appl Physiol. 2006;101(4):1025–35.PubMedCrossRefGoogle Scholar
  94. 94.
    Guenette JA, Webb KA, O’Donnell DE. Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD? Eur Respir J. 2012;40(2):322–9.PubMedCrossRefGoogle Scholar
  95. 95.
    Hudson AL, Laveneziana P. Do we “drive” dyspnoea? Eur Respir J. 2015;45(2):301–4.PubMedCrossRefGoogle Scholar
  96. 96.
    Lanini B, et al. Perception of dyspnea in patients with neuromuscular disease. Chest. 2001;120(2):402–8.PubMedCrossRefGoogle Scholar
  97. 97.
    O’Donnell DE, Chau LK, Webb KA. Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. J Appl Physiol. 1998;84(6):2000–9.PubMedCrossRefGoogle Scholar
  98. 98.
    O’Donnell DE, et al. Ventilatory assistance improves exercise endurance in stable congestive heart failure. Am J Respir Crit Care Med. 1999;160(6):1804–11.PubMedCrossRefGoogle Scholar
  99. 99.
    Laveneziana P, et al. Effect of biventricular pacing on ventilatory and perceptual responses to exercise in patients with stable chronic heart failure. J Appl Physiol. 2009;106(5):1574–83.PubMedCrossRefGoogle Scholar
  100. 100.
    Laveneziana P, et al. Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2013;41(3):578–87.PubMedCrossRefGoogle Scholar
  101. 101.
    Laveneziana P, et al. Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations. Eur Respir J. 2014;44(4):1069–72.PubMedCrossRefGoogle Scholar
  102. 102.
    Laveneziana P, et al. Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2015;45(5):1495–8.PubMedCrossRefGoogle Scholar
  103. 103.
    DeLorey DS, Wyrick BL, Babb TG. Mild-to-moderate obesity: implications for respiratory mechanics at rest and during exercise in young men. Int J Obes. 2005;29(9):1039–47.CrossRefGoogle Scholar
  104. 104.
    Ofir D, et al. Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol. 2007;102(6):2217–26.PubMedCrossRefGoogle Scholar
  105. 105.
    Romagnoli I, et al. Role of hyperinflation vs. deflation on dyspnoea in severely to extremely obese subjects. Acta Physiol (Oxford). 2008;193(4):393–402.CrossRefGoogle Scholar
  106. 106.
    Laveneziana P, et al. Tidal volume inflection and its sensory consequences during exercise in patients with stable asthma. Respir Physiol Neurobiol. 2012;185(2):374–9.PubMedCrossRefGoogle Scholar
  107. 107.
    Laveneziana P, et al. Mechanisms of dyspnoea and its language in patients with asthma. Eur Respir J. 2006;27(4):742–7.PubMedCrossRefGoogle Scholar
  108. 108.
    Lougheed MD, Fisher T, O’Donnell DE. Dynamic hyperinflation during bronchoconstriction in asthma: implications for symptom perception. Chest. 2006;130(4):1072–81.PubMedCrossRefGoogle Scholar
  109. 109.
    Moy ML, et al. Quality of dyspnea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med. 2000;162(2 Pt 1):451–5.PubMedCrossRefGoogle Scholar
  110. 110.
    Lougheed MD, et al. Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. Am Rev Respir Dis. 1993;148(6 Pt 1):1452–9.PubMedCrossRefGoogle Scholar
  111. 111.
    Ottanelli R, et al. Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest. 2001;120(3):770–7.PubMedCrossRefGoogle Scholar
  112. 112.
    Ottanelli R, et al. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clin Sci (Lond). 2000;98(6):681–7.CrossRefGoogle Scholar
  113. 113.
    Killian KJ, et al. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med. 2000;162(2 Pt 1):490–6.PubMedCrossRefGoogle Scholar
  114. 114.
    Gorini M, et al. Chest wall hyperinflation during acute bronchoconstriction in asthma. Am J Respir Crit Care Med. 1999;160(3):808–16.PubMedCrossRefGoogle Scholar
  115. 115.
    Filippelli M, et al. Overall contribution of chest wall hyperinflation to breathlessness in asthma. Chest. 2003;124(6):2164–70.PubMedCrossRefGoogle Scholar
  116. 116.
    Moy ML, et al. Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol. Am J Respir Crit Care Med. 1998;158(3):749–53.PubMedCrossRefGoogle Scholar
  117. 117.
    Barreiro E, et al. Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J. 2004;24(2):219–25.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Ioannis Vogiatzis
    • 1
    • 2
  • Paolo Palange
    • 3
  • Pierantonio Laveneziana
    • 4
    • 5
    Email author
  1. 1.Faculty of Physical Education and Sports SciencesNational and Kapodistrian University of AthensAthensGreece
  2. 2.Faculty of Health and Life Sciences, Department of Sport, Exercise and RehabilitationNorthumbria UniversityNewcastle Upon TyneUK
  3. 3.Department of Public Health and Infectious DiseasesSapienza University of RomeRomeItaly
  4. 4.Sorbonne Universités, UPMC Université Paris 06, INSERM, UMRS_1158 Neurophysiologie Respiratoire Expérimentale et CliniqueParisFrance
  5. 5.Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière Charles FoixService des Explorations Fonctionnelles de la Respiration, de l’Exercice et de la Dyspnée (Département “R3S”, Pôle PRAGUES)ParisFrance

Personalised recommendations